T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection

被引:40
作者
Shimizu, Yukihiro [1 ]
机构
[1] Takaoka City Hosp, Gastroenterol Unit, Takaoka, Toyama 9338550, Japan
关键词
T cells; Immunopathogenesis; Immunotherapy; Hepatitis B virus infection; COLONY-STIMULATING FACTOR; CHRONIC HBV INFECTION; TRANSGENIC MICE; COMBINATION THERAPY; THYMOSIN ALPHA-1; VIRAL-HEPATITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; LAMIVUDINE TREATMENT; ANTIVIRAL THERAPY;
D O I
10.3748/wjg.v18.i20.2443
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B is caused by the host immune response and T cells play a major role in the immunopathogenesis. More importantly, T cells not only destroy hepatocytes infected by hepatitis B virus (HBV), but also control HBV replication or eradicate HBV in a noncytolytic manner. Therefore, analysis of T cell immune response during acute and chronic HBV infection is important to develop a strategy for successful viral control, which could lead to immunotherapy for terminating persistent HBV infection. There have been many attempts at immunotherapy for chronic HBV infection, and some have shown promising results. High viral load has been shown to suppress antiviral immune responses and immunoinhibitory signals have been recently elucidated, therefore, viral suppression by nucleos(t)ide analogs, stimulation of antiviral immune response, and suppression of the immunoinhibitory signals must be combined to achieve desirable antiviral effects. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2443 / 2451
页数:9
相关论文
共 77 条
  • [1] Akbar SMF, 1997, J HEPATOL, V26, P131
  • [2] Combination Therapy with Antiviral Drugs and Hepatitis B Vaccine in Incidentally-Detected and Asymptomatic Chronic Hepatitis Virus B Carriers at Bangladesh
    Al-Mahtab, Mamun
    Rahman, Salimur
    Akbar, Sheikh Mohammad Fazle
    Khan, Sakirul Islam
    Uddin, Helal
    Karim, Fazal
    Ahmed, Faroque
    [J]. VIRAL IMMUNOLOGY, 2010, 23 (03) : 335 - 338
  • [3] A pilot study of thymosin α1 therapy for chronic hepatitis B patients
    Arase, Y
    Tsubota, A
    Suzuki, Y
    Suzuki, F
    Kobayashi, M
    Someya, T
    Akuta, N
    Hosaka, T
    Saitoh, S
    Ikeda, K
    Kobayashi, M
    Kumada, H
    [J]. INTERNAL MEDICINE, 2003, 42 (10) : 941 - 946
  • [4] Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type I response in vitro:: mechanisms for viral immune escape
    Beckebaum, S
    Cicinnati, VR
    Zhang, X
    Ferencik, S
    Frilling, A
    Grosse-Wilde, H
    Broelsch, CE
    Gerken, G
    [J]. IMMUNOLOGY, 2003, 109 (04) : 487 - 495
  • [5] Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections
    Bertoletti, A
    DElios, MM
    Boni, C
    DeCarli, M
    Zignego, AL
    Durazzo, M
    Missale, G
    Penna, A
    Fiaccadori, F
    DelPrete, G
    Ferrari, C
    [J]. GASTROENTEROLOGY, 1997, 112 (01) : 193 - 199
  • [6] Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
    Boni, C
    Penna, A
    Ogg, GS
    Bertoletti, A
    Pilli, M
    Cavallo, C
    Cavalli, A
    Urbani, S
    Boehme, R
    Panebianco, R
    Fiaccadori, F
    Ferrari, C
    [J]. HEPATOLOGY, 2001, 33 (04) : 963 - 971
  • [7] Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
    Cavanaugh, VJ
    Guidotti, LG
    Chisari, FV
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3236 - 3243
  • [8] Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B
    Chen, Ji
    Wang, Xiao-Mei
    Wu, Xue-Jie
    Wang, Yan
    Zhao, Hong
    Shen, Bing
    Wang, Gui-Qiang
    [J]. INFLAMMATION RESEARCH, 2011, 60 (01) : 47 - 53
  • [9] Chen M, 2005, WORLD J GASTROENTERO, V11, P1806, DOI 10.3748/wjg.v11.i12.1806
  • [10] Cytotoxic T cells and viral hepatitis
    Chisari, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1472 - 1477